Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countries

By Bresee J.S.   Glass R.I.   Ivanoff B.   Gentsch J.R.  

Vaccine, Vol. 17, Iss. 18, 1999-05 ,pp. : 2207-2222

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12

By Bernstein D.I.   Smith V.E.   Sherwood J.R.   Schiff G.M.   Sander D.S.   DeFeudis D.   Spriggs D.R.   Ward R.L.  

Vaccine, Vol. 16, Iss. 4, 1998-02 ,pp. : 381-387

Elsevier

Access to resources Recommend Favorite

Early phase II trial of human rotavirus vaccine candidate RV3

By Barnes G.L.   Lund J.S.   Mitchell S.V.   De Bruyn L.   Piggford L.   Smith A.L.   Furmedge J.   Masendycz P.J.   Bugg H.C.   Bogdanovic-Sakran N.   Carlin J.B.   Bishop R.F.  

Vaccine, Vol. 20, Iss. 23, 2002-07 ,pp. : 2950-2956

Elsevier

Access to resources Recommend Favorite

Immunogenicity and protective efficacy of a formalin-inactivated rotavirus vaccine combined with lipid adjuvants

By Johansen K.   Schroder U.   Svensson L.  

Vaccine, Vol. 21, Iss. 5, 2003-01 ,pp. : 368-375

Elsevier

Access to resources Recommend Favorite

Biochemical and immunologic comparison of virus-like particles for a rotavirus subunit vaccine

By Madore H.P.   Estes M.K.   Zarley C.D.   Hu B.   Parsons S.   Digravio D.   Greiner S.   Smith R.   Jiang B.   Corsaro B.   Barniak V.   Crawford S.   Conner M.E.  

Vaccine, Vol. 17, Iss. 19, 1999-05 ,pp. : 2461-2471

Elsevier

Access to resources Recommend Favorite